NSC107340

dc.creatorUS National Cancer Institute
dc.date2005-08-31T10:47:38Z
dc.date2005-08-31T10:47:38Z
dc.date2003-02-01
dc.date2005-08-31T10:47:38Z
dc.date.accessioned2026-08-03T04:20:30Z
dc.format6274 bytes
dc.format5906 bytes
dc.formatchemical/x-cml
dc.formatchemical/x-cml
dc.formatchemical/x-cml
dc.formatchemical/x-cml
dc.identifierNSC107340
dc.identifierhttp://www.dspace.cam.ac.uk/handle/1810/88378
dc.identifierIBAXMBJWBAUBDE-UHFFFAOYSA-N
dc.identifierInChI=1S/C16H19BrN4/c1-12-2-4-13(5-3-12)20-6-8-21(9-7-20)16-14(17)10-19-11-15(16)18/h2-5,10-11H,6-9,18H2,1H3
dc.identifierC16H19BrN4,1H3-12-2H-4H-13(5H-3H-12)20-8H2-10H2-21(11H2-9H2-20)16-14(17)6H-19-7H-15(16)18H2
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/188059
dc.languageen_GB
dc.publisherUnilever Center for Molecular Informatics, Cambridge University
dc.titleNSC107340
dc.titlePiperazine, 1-(3-amino-5-bromo-4-pyridyl)-4-(p-tolyl)-
dc.titleWLN: T6N DNTJ AR D1& D- DT6NJ CZ EE
dc.title1-(3-Amino-5-bromo-4-pyridyl)-4-(p-tolyl)piperazine
dc.title3-Pyridinamine, 5-bromo-4-[4-(4-methylphenyl)-1-piperazinyl]- (9CI)
dc.title4-(p-Tolyl)-1-(3-amino-5-bromo-4-pyridyl)piperazine
dc.typeChemical Structures

Files